Edelweiss BSE Sensex ETF
Edelweiss Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +5.53% | +3.62% | 43 of 229 |
| 1M | +7.53% | +2.76% | 23 of 227 |
| 3M | -1.37% | -3.72% | 54 of 227 |
| 6M | +0.79% | -0.45% | 97 of 218 |
| YTD | -8.47% | -3.05% | 194 of 229 |
| INCEPTION | -8.94% | — | — |
Ranked among: Exchange Traded Funds (ETFs) - Other ETF.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | -3.37% | +6.81% | -15.48% | 32% | 10% |
| 6M | -5.80% | +3.68% | -13.33% | 6% | -1% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity99.90%
- Debt0.00%
- Cash0.10%
- Other0.00%
Market Cap Split
- Large Cap99.90%
- Mid Cap0.00%
- Small Cap0.00%
- Others0.10%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 19.57 | — |
| P/B | 2.66 | — |
| Price / Sales | 2.95 | — |
| Price / Cash Flow | 13.24 | — |
| Dividend Yield (%) | 1.75 | — |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| HDFC Bank | Banks | 12.58% | +0.74% |
| ICICI Bank | Banks | 11.02% | -0.37% |
| Reliance Industries | Petroleum Products | 9.15% | -0.38% |
| Bharti Airtel | Telecom - Services | 6.37% | +0.26% |
| Larsen & Toubro | Construction | 5.10% | -0.07% |
| State Bank of India | Banks | 4.63% | -0.20% |
| Infosys | IT - Software | 4.08% | -0.23% |
| Axis Bank | Banks | 4.08% | +0.06% |
| Kotak Bank | Banks | 3.57% | +0.20% |
| Mahindra & Mahindra | Automobiles | 3.06% | -0.20% |
| Bajaj Finance | Finance | 2.99% | -0.13% |
| ITC | Diversified FMCG | 2.96% | +0.25% |
| Eternal | Retailing | 2.69% | +0.09% |
| Tata Consultancy Services | IT - Software | 2.41% | -0.22% |
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 2.28% | -0.03% |
View all 33 holdings
| Titan | Consumer Durables | 2.18% | -0.11% |
| Hindustan Unilever | Diversified FMCG | 1.95% | +0.00% |
| Maruti Suzuki | Automobiles | 1.79% | -0.11% |
| NTPC | Power | 1.78% | +0.07% |
| Tata Steel | Ferrous Metals | 1.77% | +0.11% |
| Adani Ports & SEZ | Transport Infrastructure | 1.62% | +0.30% |
| Bharat Electronics | Aerospace & Defense | 1.62% | -0.01% |
| HCL Technologies | IT - Software | 1.51% | -0.01% |
| UltraTech Cement | Cement & Cement Products | 1.50% | +0.02% |
| Power Grid Corporation of India | Power | 1.38% | +0.06% |
| Interglobe Aviation | Transport Services | 1.30% | +0.03% |
| Asian Paints | Consumer Durables | 1.26% | -0.01% |
| Tech Mahindra | IT - Software | 1.13% | +0.00% |
| Bajaj Finserv | Finance | 1.13% | -0.11% |
| Trent | Retailing | 1.01% | -0.03% |
| Clearing Corporation of India Ltd. | Net Current Assets | 0.07% | — |
| Net Receivables/(Payables) | Net Current Assets | 0.03% | — |
| Accrued Interest | Net Current Assets | 0.00% | — |
Sector Allocation · Sep 2026
View all 17 sectors
Risk Metrics
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 3Y | -1.14 | -1.59 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Motilal Oswal Nasdaq Q50 ETF | +33.42% | +31.36% | — | +12.73% |
| Tata Silver Exchange Traded Fund | +26.44% | — | — | +39.36% |
|
SBI Silver ETF
Regular Plan · Growth
|
+26.42% | — | — | +34.10% |
| Kotak Silver ETF | +26.35% | +36.48% | — | +28.03% |
| ICICI PRUDENTIAL SILVER ETF | +26.35% | +36.57% | — | +24.10% |
| Edelweiss Silver ETF | +26.32% | — | — | +35.41% |
| Motilal Oswal Silver ETF | +26.09% | — | — | +46.27% |
|
Nippon India Silver ETF
Direct Plan
|
+26.05% | +36.23% | — | +25.08% |
|
HDFC Silver ETF
Growth Option
|
+25.77% | +36.06% | — | +34.08% |
|
Nippon India Nifty Pharma ETF
Direct Plan
|
+22.83% | +22.93% | +15.06% | +13.35% |
More From Edelweiss Asset Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Edelweiss US Value Equity Offshore Fund
Direct Plan · Growth
|
+29.74% | +21.68% | +14.03% | +13.46% |
| Edelweiss Silver ETF | +26.32% | — | — | +35.41% |
|
Edelweiss Gold and Silver ETF FOF
Direct Plan · Growth
|
+23.25% | +34.17% | — | +30.69% |
|
Edelweiss Emerging Markets Opportunities Equity Offshore Fund
Direct Plan · Growth
|
+22.43% | +25.06% | +9.43% | +11.36% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+20.88% | +21.50% | +14.91% | +16.74% |
|
Edelweiss Recently Listed IPO Fund
Direct Plan · Growth
|
+20.01% | +17.71% | +10.98% | +15.60% |
| Edelweiss Gold ETF | +16.79% | — | — | +31.46% |
|
Edelweiss Europe Dynamic Equity Offshore Fund
Direct Plan · Growth
|
+16.72% | +25.29% | +14.57% | +13.15% |
|
Edelweiss ASEAN Equity Off-shore Fund
Direct Plan · Growth
|
+6.68% | +14.36% | +7.41% | +8.53% |
|
Edelweiss Equity Savings Fund
Direct Plan · Growth
|
+6.67% | +11.23% | +9.52% | +10.47% |
About This Scheme
Investment Objective
To generate returns that are in line with the performance of the BSE Sensex Total Return Index, subject to tracking errors. There is no assurance that the investment objective of the Scheme will be achieved.
Stated Asset Allocation
1. Securities covered by BSE Sensex ETF - 95 - 100% 2. Money Market Instruments#, cash and cash equivalent and/or units of Liquid scheme - 0 - 5%
Exit Load
NIL
Fund Managers
Mr. Bhavesh Jain, Ms. Manasi Jalgaonkar
Primary, Ms. Manasi Jalgaonkar - Assistant Fund Manager
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch